Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermal collagen fibers are thick bundles of fibrillar collagen, mainly types I and III, found in the dermis of the skin. These fibers provide the skin with its principal mechanical strength, tensile resilience, structural support, and elasticity[1][2][4][5][7][8]. They are organized in crisscrossed networks that define the mechanical and viscoelastic properties of skin and serve as the anchoring scaffold for cells and extracellular molecules, including blood vessels and glands. Collagen fibers are synthesized by dermal fibroblasts and undergo extensive post-translational modifications and crosslinking, forming macrofibrils that resist mechanical stress. With aging or photo-damage, these fibers become fragmented, disorganized, stiffer, and less functional, which underlies wrinkles, loss of elasticity, delayed wound healing, and increased vulnerability to injury[2][6][7][8]. Although not a pharmaceutical target in the classical sense (like a receptor or enzyme), dermal collagen fibers are a focus for interventions directed at enhancing skin integrity, anti-aging, or wound repair via modulation of their synthesis, degradation, or organization. Note: - "Dermal collagen fiber" is not a classical therapeutic target such as a receptor, ion channel, or enzyme. It is rather a major extracellular structural component, and so the entry is, strictly speaking, not a molecular target in the sense used for pharmacological intervention[1][3][5]. - Some confusion may arise as "Dermal collagen fibers" is sometimes listed in error as a drug target. The actual targets for modulation are usually the enzymes involved in collagen synthesis or degradation (e.g., MMPs, lysyl oxidase), or the fibroblasts that produce collagen. Summary for structuring: - This entry is best classified as a structural protein/fiber, not a molecular receptor/target. - For structured databases of drug targets, list as is_target: false, is_incorrect: true, and direct users to more specific molecular targets involved in collagen metabolism (such as "Type I collagen", "MMP-1", or "procollagen synthase").
Not directly targeted as a receptor/target Modulation of synthesis, crosslinking, or degradation via fibroblast activity or enzyme inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermal collagen fiber.